Clinical Roundup Cancer Center at Illinois researcher unveils targeting technology for cancer immunotherapy September 12, 2025Vol.51 No.33
Clinical Roundup WashU Medicine genetic study suggests ways to catch blood cancer earlier September 12, 2025Vol.51 No.33
Drugs & Targets FDA approves gemcitabine intravesical system for non-muscle invasive bladder cancer September 12, 2025Vol.51 No.33
Drugs & Targets FDA grants Hernexeo Breakthrough Therapy designation as first line use for HER2-mutant advanced NSCLC September 12, 2025Vol.51 No.33
Drugs & Targets FDA seeks academic and patient advocate research partners for oncology data analysis September 12, 2025Vol.51 No.33
Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing September 05, 2025Vol.51 No.32By Jacquelyn Cobb
Capitol Hill House committee’s FY26 spending bill increases NCI funding by $48M, NIH by $99MHouse joins Senate in rejecting Trump’s proposed 40% NIH cuts September 05, 2025Vol.51 No.32By Jacquelyn Cobb and Paul Goldberg
NCI Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost September 05, 2025Vol.51 No.32By Jacquelyn Cobb
Capitol Hill With CDC in free fall, RFK Jr. faces bipartisan rebuke at Senate hearingKennedy calls CDC “the most corrupt agency at HHS and maybe the government.” September 05, 2025Vol.51 No.32By Claire Marie Porter
